Emma Killick

716 total citations
7 papers, 253 citations indexed

About

Emma Killick is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emma Killick has authored 7 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emma Killick's work include Cancer-related Molecular Pathways (3 papers), Sarcoma Diagnosis and Treatment (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). Emma Killick is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Sarcoma Diagnosis and Treatment (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). Emma Killick collaborates with scholars based in United Kingdom, Australia and Netherlands. Emma Killick's co-authors include Rosalind A. Eeles, Judy Kirk, Mandy L. Ballinger, Kate A. McBride, David M. Thomas, Martin H.N. Tattersall, Gillian Mitchell, Elizabeth Bancroft, Zsofia Kote‐Jarai and Leslie G. Walker and has published in prestigious journals such as PLoS ONE, Nature Reviews Clinical Oncology and Clinical & Experimental Immunology.

In The Last Decade

Emma Killick

7 papers receiving 246 citations

Peers

Emma Killick

ONCOL

MB

CR

GENET

PRM

Kelvin C. de Andrade United States

Marianne Brodtkorb Eide Norway

Mariëlle Ruijs Netherlands

Prosser Prosser

Lurdes Torres Portugal

Eden United States

Hayley E. Spendlove United Kingdom

Jolijn W. Groeneweg Netherlands

Arianna Citti Italy

Eliza Wickham‐Garcia United States

Kelvin C. de Andrade United States

Emma Killick

149 ×1.1

ONCOL

128 ×1.1

MB

91 ×1.3

CR

70 ×1.1

GENET

22 ×0.5

PRM

Citations per year, relative to Emma Killick Emma Killick (= 1×) peers Kelvin C. de Andrade

Countries citing papers authored by Emma Killick

Since Specialization

Citations

This map shows the geographic impact of Emma Killick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Killick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Killick more than expected).

Fields of papers citing papers by Emma Killick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Killick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Killick. The network helps show where Emma Killick may publish in the future.

Co-authorship network of co-authors of Emma Killick

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Killick. A scholar is included among the top collaborators of Emma Killick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Killick. Emma Killick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

McBride, Kate A., Mandy L. Ballinger, Timothy E. Schlub, et al.. (2017). Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?. Familial Cancer. 16(3). 423–432. 34 indexed citations

2.

Biswas, Swethajit, Emma Killick, Aart G. Jochemsen, & John Lunec. (2014). The clinical development of p53-reactivating drugs in sarcomas – charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins. Expert Opinion on Investigational Drugs. 23(5). 629–645. 7 indexed citations

3.

McBride, Kate A., Mandy L. Ballinger, Emma Killick, et al.. (2014). Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nature Reviews Clinical Oncology. 11(5). 260–271. 186 indexed citations

4.

Killick, Emma, Malgorzata Tymrakiewicz, Clara Cieza-Borrella, et al.. (2014). Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status. PLoS ONE. 9(1). e86659–e86659. 10 indexed citations

5.

Annels, Nicola, Guy R. Simpson, M. Denyer, et al.. (2014). Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer. Clinical & Experimental Immunology. 177(2). 428–438. 3 indexed citations

6.

Killick, Emma, J.A. Bennett, Andrew Bates, et al.. (2014). 26 Treatment and outcome in epidermal growth factor receptor mutant non-small cell lung cancer: A retrospective audit across four NHS trusts. Lung Cancer. 83. S10–S11. 1 indexed citations

7.

Killick, Emma, Elizabeth Bancroft, Zsofia Kote‐Jarai, & Rosalind A. Eeles. (2012). Beyond Prostate-specific Antigen — Future Biomarkers for the Early Detection and Management of Prostate Cancer. Clinical Oncology. 24(8). 545–555. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact